Hoechst 33342
Alternative Names: HO 33342; HOE 33342Latest Information Update: 17 Jul 2001
At a glance
- Originator Aventis
- Class
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 17 Jul 2001 Discontinued-Unspecified phase in Cancer in USA (Unknown route)
- 13 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)